Interferons: all 58 studies that test it
Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B DrugsRecruitingNCT07069569Phase 2
- Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid LeukemiaRecruitingNCT06802718Phase 3
- Antiviral Therapy in Infants With HBV InfectionNot yet recruitingNCT06503796Phase 4
- Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial CystitisNot yet recruitingNCT05912946Phase 2/3
- A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis BCompletedNCT04225715Phase 2Results posted
- SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV InfectionCompletedNCT01962441Phase 3Results posted
- Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV InfectionCompletedNCT01826981Phase 2Results posted
- 5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung CancerCompletedNCT01658813Phase 2Results posted
- Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044)CompletedNCT01405937Phase 3Results posted
- Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045)CompletedNCT01405560Phase 3Results posted
- Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis BCompletedNCT01277601Phase 4Results posted
- Intravenous Interferon During Liver TransplantCompletedNCT01192698Not applicableResults posted
- A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment FailuresCompletedNCT01185028Phase 1/2Results posted
- Study of CTS-1027 in Combination With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Null-RespondersCompletedNCT01051921Phase 2Results posted
- High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1CompletedNCT00735969Phase 2Results posted
- Peginterferon α-2b as a Maintenance Therapy in Participants With Multiple Myeloma Who Responded to Induction Therapy (P01972-AM7)CompletedNCT00732641Phase 3Results posted
- A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer.TerminatedNCT00678288Phase 2Results posted
- Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin ResistanceCompletedNCT00665353Phase 2Results posted
- PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis CCompletedNCT00100659Phase 3Results posted
- Treatment and Natural History Study of Lymphomatoid GranulomatosisCompletedNCT00001379Phase 2Results posted
- The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B PatientsCompletedNCT03546530Not applicable
- A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis BStatus unknownNCT03357822Phase 4
- Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic ImpairmentCompletedNCT02259855Phase 1
- Optimized Treatment and Regression of HBV-induced Liver FibrosisCompletedNCT01938781Phase 4
- Open Label Trial to Compare BI 207127 to Telaprevir in HCV PatientsWithdrawnNCT01858961Phase 3
- A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)Status unknownNCT01731301Phase 4
- Vitamin D as an add-on Therapy With Pegylated Interferon and Ribavirin for Chronic Hepatitis cStatus unknownNCT01655966Phase 3
- Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV DiseaseCompletedNCT01605513Phase 1/2
- Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver CirrhosisStatus unknownNCT01483248Phase 1/2
- Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC)Status unknownNCT01457937Phase 3
- IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic MelanomaWithdrawnNCT01409187Phase 1/2
- Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis CStatus unknownNCT01327729Phase 2/3
- Advanced Cervical Cancer Trial in IndiaCompletedNCT01276730Phase 2
- A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid LeukemiaCompletedNCT01227356Phase 2
- Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid PharmacotherapyCompletedNCT01120795Phase 4
- Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic LeukemiaWithdrawnNCT00962715Phase 1/2
- Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian EthnicityCompletedNCT00957866Phase 4
- Role of Heme Oxygenase in the Pathogenesis of Hepatocellular Injury in Chronic Hepatitis C Virus (HCV) InfectionStatus unknownNCT00842205Not applicable
- Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)CompletedNCT00788918Not applicable
- Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9CompletedNCT00575224Phase 4
- Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary BladderCompletedNCT00539773Not applicable
- Evaluation of a Multi-disciplinary Approach for the Treatment of Hepatitis C in IDUs (HI-LO Study)CompletedNCT00399672Not applicable
- Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid LeukaemiaCompletedNCT00390897Phase 4
- Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.CompletedNCT00383864Phase 4
- A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV)CompletedNCT00328549Phase 2
- NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus CoinfectionCompletedNCT00315432Phase 2
- Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell CarcinomaTerminatedNCT00311467Phase 3
- Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes CCompletedNCT00309530Phase 3
- Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib TherapyStatus unknownNCT00297570Phase 3
- Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or MyelomaCompletedNCT00276536Phase 1
- VX-950 and Peginterferon for Hepatitis CCompletedNCT00251199Phase 1
- Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00250796Phase 2
- Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B PatientsCompletedNCT00226447Phase 2
- Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug UsersCompletedNCT00194480Phase 4
- Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected PatientsCompletedNCT00132210Phase 4
- Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard TherapyCompletedNCT00120861Phase 2
- Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis CCompletedNCT00120835Phase 1/2
- Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell CancerCompletedNCT00001228Phase 2